BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36591313)

  • 21. Protective immunity to Pasteurella multocida heat-labile toxin by intranasal immunization in rabbits.
    Suckow MA; Bowersock TL; Nielsen K; Chrisp CE; Frandsen PL; Janovitz EB
    Lab Anim Sci; 1995 Oct; 45(5):526-32. PubMed ID: 8569151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Galpha (i) and subsequent uncoupling of receptor-Galpha(i) signaling by Pasteurella multocida toxin.
    Orth JH; Fester I; Preuss I; Agnoletto L; Wilson BA; Aktories K
    J Biol Chem; 2008 Aug; 283(34):23288-94. PubMed ID: 18583341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.
    Wilson BA; Ho M
    FEBS J; 2011 Dec; 278(23):4616-32. PubMed ID: 21569202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pasteurella multocida toxin: the mitogenic toxin that stimulates signalling cascades to regulate growth and differentiation.
    Lax AJ; Grigoriadis AE
    Int J Med Microbiol; 2001 Sep; 291(4):261-8. PubMed ID: 11680786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-silico analysis of Pasteurella multocida to identify common epitopes between fowl, goat and buffalo.
    Ghaffar A; Tariq A
    Gene; 2016 Apr; 580(1):58-66. PubMed ID: 26779825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pasteurella multocida toxin interaction with host cells: entry and cellular effects.
    Wilson BA; Ho M
    Curr Top Microbiol Immunol; 2012; 361():93-111. PubMed ID: 22552700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
    Seo J; Lee S; Pyo H; Lee J; Kim T
    Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of nasal turbinate atrophy in germ-free pigs, using Pasteurella multocida as well as bacterium-free crude and purified dermonecrotic toxin of P multocida.
    Kamp EM; Kimman TG
    Am J Vet Res; 1988 Nov; 49(11):1844-9. PubMed ID: 3247905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A minimal medium for growth of Pasteurella multocida.
    Jablonski PE; Jaworski M; Hovde CJ
    FEMS Microbiol Lett; 1996 Jul; 140(2-3):165-9. PubMed ID: 8764479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of protective immunity in rabbits by coadministration of inactivated Pasteurella multocida toxin and potassium thiocyanate extract.
    Jarvinen LZ; Hogenesch H; Suckow MA; Bowersock TL
    Infect Immun; 1998 Aug; 66(8):3788-95. PubMed ID: 9673263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pasteurella multocida toxin activates various heterotrimeric G proteins by deamidation.
    Orth JH; Aktories K
    Toxins (Basel); 2010 Feb; 2(2):205-14. PubMed ID: 22069582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative.
    Nielsen JP; Foged NT; Sørensen V; Barfod K; Bording A; Petersen SK
    Can J Vet Res; 1991 Apr; 55(2):128-38. PubMed ID: 1832079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of toxin in strains previously classified as Pasteurella multocida.
    Nielsen JP; Bisgaard M; Pedersen KB
    Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):203-4. PubMed ID: 3739718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
    Suckow MA
    Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytosolic Delivery of Multidomain Cargos by the N Terminus of Pasteurella multocida Toxin.
    Clemons NC; Bannai Y; Haywood EE; Xu Y; Buschbach JD; Ho M; Wilson BA
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29784857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pasteurella multocida toxin is a potent activator of anti-apoptotic signalling pathways.
    Preuss I; Hildebrand D; Orth JH; Aktories K; Kubatzky KF
    Cell Microbiol; 2010 Aug; 12(8):1174-85. PubMed ID: 20331638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxin production by Pasteurella multocida isolated from rabbits with atrophic rhinitis.
    DiGiacomo RF; Deeb BJ; Brodie SJ; Zimmerman TE; Veltkamp ER; Chrisp CE
    Am J Vet Res; 1993 Aug; 54(8):1280-6. PubMed ID: 8214896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration that Australian Pasteurella multocida isolates from sporadic outbreaks of porcine pneumonia are non-toxigenic (toxA-) and display heterogeneous DNA restriction endonuclease profiles compared with toxigenic isolates from herds with progressive atrophic rhinitis.
    Djordjevic SP; Eamens GJ; Ha H; Walker MJ; Chin JC
    J Med Microbiol; 1998 Aug; 47(8):679-88. PubMed ID: 9877188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
    Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
    Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.